[1][2][3] Steeg attended the University of Maryland, which is where she got her PhD in 1982.
[1] Steeg had been the Deputy Chief of the Women’s Malignancies Branch since 2014 at the Center for Cancer Research[1] as well as being the co-director of the Office of Translational Resources for the Center.
[1] Steeg was also a recipient of the Jane Coffin Child Memorial Fund for Medical Research Fellowship in the Laboratory of Departmental Biology and Anomalies,[1] as well as the National Institute of Dental Research, and the Laboratory of Pathology at the National Cancer Institute.
[4] When the NME1 gene is introduced in highly metastatic breast cancer line it decreased the potential for the cancer to spread anywhere from 50 to 90 percent.
[5] This means that cancerous cells will lack this protein, so Steeg and her team synthesized a drug called nitidine analog that will locate cancerous cells and destroy them based on the amount of proteins the cell contains.